Pictured: Jatin Shah
Video
By Memorial Sloan Kettering  |  Tuesday, February 28, 2012

Many cancers that develop in the mouth, nose, throat, and larynx can be cured. Watch this series to learn how our experts collaborate to give patients the best chance of a positive outcome.

Pictured: Ann Zauber
In the Clinic
By Esther Napolitano, BS and Julie Grisham, MS
Thursday, February 23, 2012

For the first time, a new study has shown that removing polyps by colonoscopy not only prevents colorectal cancer from developing, but also prevents deaths from the disease.

Patient Story
By Memorial Sloan Kettering  |  Monday, February 20, 2012

When five-year-old CJ Postighone was diagnosed with a rare pediatric cancer called rhabdomyosarcoma, he came to Memorial Sloan Kettering to receive a combination of surgery, chemotherapy, and radiation therapy.

Pictured: Mark Bilsky
Q&A
By Memorial Sloan Kettering  |  Wednesday, February 15, 2012

The director of the Spine Tumor Center explains how this new, high-powered approach to radiation therapy has changed the way spine tumors are treated at Memorial Sloan Kettering.

Pictured: Halina Frydman
Patient Story
By Memorial Sloan Kettering  |  Monday, February 13, 2012

Soon after Halina Frydman’s husband noticed changes in his wife's personality, Halina was diagnosed with primary central nervous system lymphoma. She came to Memorial Sloan Kettering to receive treatment through a clinical trial.

Pictured: Robert Motzer
In the Clinic
By Esther Napolitano, BS, Science Writer/Editor  |  Tuesday, February 7, 2012

The recent FDA approval of axitinib provides a viable treatment option for patients who progress on or cannot tolerate the side effects of other approved drugs for the disease.

Pictured: Memorial Sloan Kettering logo
In the News
By Julie Grisham, MS, Science Writer/Editor  |  Monday, February 6, 2012

Two of the year’s top five cancer research advances cited by the American Society of Clinical Oncology were led by Memorial Sloan Kettering investigators.

Pictured: Charles Sawyers & Howard Scher
In the News
By Media Staff  |  Friday, February 3, 2012

The success of an experimental prostate cancer treatment is an example of how academic research centers are playing a larger role in drug development, the Wall Street Journal reports.

Pictured: Marc Ladanyi & Laetitia Borsu
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Wednesday, February 1, 2012

Memorial Sloan Kettering researchers have performed the first large-scale genetic analysis of several pediatric cancers, identifying mutations and potential targets for therapies to treat the cancers.

Pictured: Monica Morrow
Perspective
By Eva Kiesler, PhD, Science Writer/Editor  |  Tuesday, January 31, 2012

Breast Surgical Service Chief Monica Morrow provides perspective on assessing the quality of surgical breast cancer treatment in an editorial in the February 1 issue of the Journal of the American Medical Association.

Pictured: Stephanie Luedke
Patient Story
By Memorial Sloan Kettering  |  Monday, January 30, 2012

While a diagnosis of cervical cancer once required a hysterectomy, a procedure called a radical trachelectomy eliminated Stephanie Luedke’s cancer and preserved her ability to bear a child.

Prediction Tool
By Memorial Sloan Kettering  |  Wednesday, January 25, 2012

Our ovarian cancer nomogram is a personalized tool that can help you and your doctor make important treatment decisions after surgery.

Finding
By Esther Napolitano, BS, Science Writer/Editor  |  Monday, January 23, 2012

Research has shown that children who have experienced a sunburn at an early age are at almost double the risk for developing melanoma in adulthood. Now, a new study led by Memorial Sloan Kettering epidemiologist Stephen Dusza finds that most children do not regularly use sunscreen.

Pictured: Eric Pamer
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Friday, January 20, 2012

Infections are a common cause of complications in cancer patients. Now a Memorial Sloan Kettering research team finds that a commonly prescribed antibiotic could increase susceptibility to a bacterial infection.

Pictured: Michael Quinlan
Patient Story
By Memorial Sloan Kettering  |  Thursday, January 19, 2012

When actor Michael Quinlan was diagnosed with prostate cancer, he came to Memorial Sloan Kettering to learn about treatment options from our multidisciplinary team of experts. After undergoing robot-assisted laparoscopic surgery, he remains cancer-free.

Center News

Stay Informed

Get the latest information about cancer care and research every month.